Safety of a new treatment for spinal cord injury
Part of Brain & nervous system, Injuries & trauma clinical trials.
This study tests whether a new medicine called CRIS100 is safe for people who have just had a spinal cord injury. It's given early after injury (within 72 hours) to see if it can help, and the trial focuses on people with a specific type of injury (complete, mid-back).
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 70 years old.
- Have a spinal cord injury located between the T2 and T10 vertebrae (mid-back area).
- The injury must have happened less than 72 hours before surgery, and surgery must be planned.
- Must have a normal bulbocavernosus reflex (a simple reflex test your doctor checks).
- Be classified as ASIA A — meaning the injury is complete (no feeling or movement below the injury site).
- Not have severe brain injury, more than one spinal injury, or prior neurological disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new medication given into the spinal fluid can help people who have a severe spinal cord injury (complete injury) regain more function. It’s for those whose injury is not at the very top of the neck and whose spinal cord is not completely torn.
This Phase 2 trial tests sotateltide (PMZ-1620) in people with a recent spinal cord injury. It aims to see whether the drug can improve neurological recovery after injury, especially in certain levels and types of incomplete injuries.
This trial tests a new medicine called TZ-161 in people who have recently had a spinal cord injury in the chest area. The goal is to see if it is safe and can help improve movement.
This trial tests whether a mild electrical stimulation (called TENS) can help recovery after a recent spinal cord injury. It is for people who are already in the ICU with a drain in their lower back and had a blunt injury within the past 12 hours.
This trial tests a new drug called NG004 given by injection around the spinal cord. It aims to help people with recent incomplete spinal cord injuries recover function. The drug is given within the first month after injury and may be an option for those who meet the health criteria.
This study looks at people after a recent, serious injury—especially a new spinal cord injury—to see how research and clinical knowledge can be improved. Depending on your group (spinal cord injury, other trauma, or healthy), you may be invited to participate if you meet age and injury timing needs.
Hear when a new Thoracic Spinal Cord Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.